Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
17.34
+0.01 (0.06%)
At close: Apr 17, 2026, 4:00 PM EDT
17.65
+0.31 (1.79%)
After-hours: Apr 17, 2026, 7:23 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.24 billion as of April 17, 2026. Its market cap has increased by 135.29% in one year.
Market Cap
1.24B
Enterprise Value
1.18B
1-Year Change
135.29%
Ranking
Category
Stock Price
$17.34
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.24B, an increase of 866.02%. That is a compound annual growth rate of 8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.24B | 8.51% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 1.32B |
| MoonLake Immunotherapeutics | 1.32B |
| ArriVent BioPharma | 1.31B |
| Zenas BioPharma | 1.30B |
| Inhibrx Biosciences | 1.29B |
| DBV Technologies | 1.27B |
| EyePoint | 1.25B |
| AbCellera Biologics | 1.22B |